NewGenIvf Group Ltd financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
NIVF, NIVFW on Nasdaq
Latest financial report
31 Mar 2026
Location
Bangkok, Thailand

Shareable Research Card

NIVF - NewGenIvf Group Ltd Financial Facts

NIVF - NewGenIvf Group Ltd has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q4 2025
Latest reported value
Current Ratio 3.12x

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q4 2025
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q4 2025.
  • Most recent SEC facts end date on this page: 31 Dec 2025.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for NIVF - NewGenIvf Group Ltd

New fact period available

Latest financial period: Q4 2025. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

31 Mar 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 31 Mar 2026.

Open recent updates hub Open latest 10-Q/10-K hub

Benchmark Context

How Current Ratio compares

Current Ratio is up about 168% versus the comparable prior period.

Compared with

Compared with NewGenIvf Group Ltd's recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.

Why this is notable

Current Ratio already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.

  • Latest comparable period on this page: Q4 2025.
  • Peer context will appear when enough companies report a comparable value for this metric.
  • Open the metric history first if you want to verify the exact period-to-period change.

Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.

Open latest 10-Q/10-K hub

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Key facts

  • NIVF - NewGenIvf Group Ltd financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Current Ratio 3.12x.

Change

  • Current Ratio YoY change: +168%.
  • Most recent SEC facts end date: 31 Dec 2025.

Research use

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Current Ratio 3.12x and Quick Ratio 2.98x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

58.6/100

Caution Confidence low

Financial Health

Current Ratio
3.12x
Quick Ratio
2.98x

Key metrics snapshot

Financial Health

Metric Latest value YoY change
Current Ratio 3.12x +168%
Quick Ratio 2.98x +162%

Share Metrics

Metric Latest value YoY change
Common Stock, Shares, Outstanding 240,622 +63222%

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Payable, Current $779,280 -40%
Accounts Receivable, after Allowance for Credit Loss, Current $166,531 +238%
Accrued Liabilities, Current $514,169 +155%
Accumulated Other Comprehensive Income (Loss), Net of Tax $143,071 -858%
Additional Paid in Capital $17,881,176 +14496%
Assets $32,722,769 +815%
Assets, Current $7,383,571 +133%
Cash and Cash Equivalents, at Carrying Value $758,621 +66%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $758,621 +66%
Common Stock, Shares, Issued 240,622 +63222%
Contract with Customer, Liability, Current $111,981 +76%
Intangible Assets, Net (Excluding Goodwill) $21,415,069
Inventory, Net $335,360 +315%
Lessee, Operating Lease, Liability, to be Paid $565,085 +365%
Lessee, Operating Lease, Liability, to be Paid, Year One $262,244 +136%
Lessee, Operating Lease, Liability, to be Paid, Year Three $118,800
Lessee, Operating Lease, Liability, to be Paid, Year Two $184,041 +1687%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $54,621 +1807%
Liabilities $6,736,076 +33%
Liabilities and Equity $32,722,769 +815%
Liabilities, Current $2,366,351 -13%
Operating Lease, Liability $510,464 +330%
Operating Lease, Liability, Current $238,105 +119%
Operating Lease, Liability, Noncurrent $272,359 +2562%
Operating Lease, Right-of-Use Asset $504,192 +412%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 0%
Property, Plant and Equipment, Gross $3,017,388 +100%
Property, Plant and Equipment, Net $1,789,110 +555%
Retained Earnings (Accumulated Deficit) $8,893,414
Stockholders' Equity Attributable to Parent $26,631,519
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $25,986,693

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .